Original Research
Published on 24 Feb 2025
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
in Mood Disorders
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1532803
- 5,447 views
- 1 citation
